71 related articles for article (PubMed ID: 2230995)
1. Metabolism of beta-methyl-heptadecanoic acid in the perfused rat heart and liver.
Fink GD; Montgomery JA; David F; Garneau M; Livni E; Elmaleh D; Strauss HW; Brunengraber H
J Nucl Med; 1990 Nov; 31(11):1823-30. PubMed ID: 2230995
[TBL] [Abstract][Full Text] [Related]
2. Assessment of myocardial metabolism with iodine-123 heptadecanoic acid: effect of decreased fatty acid oxidation on deiodination.
Lüthy P; Chatelain P; Papageorgiou I; Schubiger A; Lerch RA
J Nucl Med; 1988 Jun; 29(6):1088-95. PubMed ID: 3373317
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and initial evaluation of 17-(11)C-heptadecanoic acid for measurement of myocardial fatty acid metabolism.
Collier TL; Hwang Y; Ramasamy R; Sciacca RR; Hickey KT; Simpson NR; Bergmann SR
J Nucl Med; 2002 Dec; 43(12):1707-14. PubMed ID: 12468523
[TBL] [Abstract][Full Text] [Related]
4. Myocardial uptake of the fatty acid analog 14-fluorine-18-fluoro-6-thia-heptadecanoic acid in comparison to beta-oxidation rates by tritiated palmitate.
Stone CK; Pooley RA; DeGrado TR; Renstrom B; Nickles RJ; Nellis SH; Liedtke AJ; Holden JE
J Nucl Med; 1998 Oct; 39(10):1690-6. PubMed ID: 9776270
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.
DeGrado TR; Wang S; Holden JE; Nickles RJ; Taylor M; Stone CK
Nucl Med Biol; 2000 Apr; 27(3):221-31. PubMed ID: 10832078
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of radioiodinated heptadecanoic acid and metabolites in the normal and ischaemic canine heart.
Visser FC; van Eenige MJ; Westera G; den Hollander W; Roos JP
Eur Heart J; 1985 Aug; 6 Suppl B():97-101. PubMed ID: 4085512
[TBL] [Abstract][Full Text] [Related]
7. Dual tracer autoradiographic study of beta-methyl-(1-14C) heptadecanoic acid and 15-p-(131I)-iodophenyl-beta-methylpentadecanoic acid in normotensive and hypertensive rats.
Yamamoto K; Som P; Brill AB; Yonekura Y; Srivastava SC; Meinken GE; Iwai J; Goodman MM; Knapp FF; Elmaleh DR
J Nucl Med; 1986 Jul; 27(7):1178-83. PubMed ID: 3723193
[TBL] [Abstract][Full Text] [Related]
8. Beta-methyl[1-11C]heptadecanoic acid: a new myocardial metabolic tracer for positron emission tomography.
Livni E; Elmaleh DR; Levy S; Brownell GL; Strauss WH
J Nucl Med; 1982 Feb; 23(2):169-75. PubMed ID: 6977020
[TBL] [Abstract][Full Text] [Related]
9. Measurement of myocardial fatty acid metabolism by iodine-123 heptadecanoic acid kinetics.
Fridrich L
J Nucl Med; 1987 May; 28(5):925-6. PubMed ID: 3572552
[No Abstract] [Full Text] [Related]
10. Measurement of myocardial fatty acid metabolism by iodine-123 heptadecanoic acid kinetics.
Feinendegen LE
J Nucl Med; 1987 May; 28(5):924-5. PubMed ID: 3572551
[No Abstract] [Full Text] [Related]
11. The myocardial elimination rate of radioiodinated heptadecanoic acid.
Visser FC; Westera G; van Eenige MJ; Van der Wall EE; Den Hollander W; Roos JP
Eur J Nucl Med; 1985; 10(3-4):118-22. PubMed ID: 3996438
[TBL] [Abstract][Full Text] [Related]
12. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial scintigraphy using omega-I-123 heptadecanoic acid (Rossendorf) in patients with coronary disease].
Lohr E; Mende T; Steinbach J; Hliscs R; Anders G; Franke WG; Beyer GJ
Cor Vasa; 1988; 30(1):18-26. PubMed ID: 3378445
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated branched-chain fatty acids: substrates for beta oxidation? Concise communication.
Otto CA; Brown LE; Scott AM
J Nucl Med; 1984 Jan; 25(1):75-80. PubMed ID: 6726426
[TBL] [Abstract][Full Text] [Related]
15. Intramyocardial fate of 15-p-iodophenyl-beta-methylpentadecanoic acid (IMPPA): is it a good tracer of fatty acid myocardial uptake?
Humbert T; Keriel C; Batlle DM; Luu-Duc C; Comet M; Cuchet P
Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):195-200. PubMed ID: 2779541
[TBL] [Abstract][Full Text] [Related]
16. 17-[4-(2-[18F]fluoroethyl)-1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic acid: a potential radiotracer for the evaluation of myocardial fatty acid metabolism.
Kim DH; Choe YS; Choi JY; Choi Y; Lee KH; Kim BT
Bioconjug Chem; 2009 Jun; 20(6):1139-45. PubMed ID: 19530707
[TBL] [Abstract][Full Text] [Related]
17. Measurement of myocardial fatty acid metabolism: kinetics of iodine-123 heptadecanoic acid in normal dog hearts.
Schön HR; Senekowitsch R; Berg D; Schneidereit M; Reidel G; Kriegel H; Pabst HW; Blömer H
J Nucl Med; 1986 Sep; 27(9):1449-55. PubMed ID: 3746446
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of iodine-123-BMIPP in perfused rat hearts.
Yamamichi Y; Kusuoka H; Morishita K; Shirakami Y; Kurami M; Okano K; Itoh O; Nishimura T
J Nucl Med; 1995 Jun; 36(6):1043-50. PubMed ID: 7769426
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
20. A comparison between terminally radioiodinated hexadecenoic acid (125I-HA) and heptadecanoic acid (131I-H0A) in the dog heart.
van der Wall EE; Westera G; Heidendal GA; den Hollander W
Eur J Nucl Med; 1981 Dec; 6(12):581-4. PubMed ID: 7333321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
